Trials / Completed
CompletedNCT02606760
Study to Evaluate the Efficacy and Safety of P-3073 Nail Solution in the Treatment of Nails Affected by Psoriasis
A Randomized, Double-blind, Vehicle-controlled, Parallel Group Trial to Assess the Efficacy, Safety and Tolerability of P-3073 for Topical Treatment of Nail Psoriasis
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 378 (actual)
- Sponsor
- Polichem S.A. · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to confirm the clinical efficacy and the safety of P-3073 in patients affected by isolated psoriatic nail(s) and/or those with psoriatic nails and concomitant mild to moderate plaque psoriasis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | P-3073 | |
| DRUG | Vehicle of P-3073 |
Timeline
- Start date
- 2015-11-23
- Primary completion
- 2017-02-08
- Completion
- 2017-02-08
- First posted
- 2015-11-17
- Last updated
- 2018-03-08
Locations
7 sites across 7 countries: Bulgaria, Czechia, Germany, Greece, Latvia, Poland, Russia
Source: ClinicalTrials.gov record NCT02606760. Inclusion in this directory is not an endorsement.